Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility
Incannex Healthcare received A$6.04 million from the Australian Government’s R&D Tax Incentive Program, adding non-dilutive capital to its balance sheet. The company expects an additional A$5.1 million in similar refunds later in 2026, bringing total expected non-dilutive proceeds to over A$11.1 million.
Key figures
- Rd tax refund expected
- 5100000
- Total non dilutive capital
- 11100000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.